Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

Abstract

The much faster absorption from subcutaneous tissue of the disubstituted monomeric insulin analogue compared with soluble insulin suggests that the analogue may be a potential candidate for rapid insulin delivery after subcutaneous bolus injection.